First-of-its-kind MDMA group therapy trial set to commence

A first-of-its-kind trial exploring MDMA-assisted therapy in a group setting being led by MAPS is about to commence following the resolution of a clinical hold placed by the US Food and Drug Administration (FDA) that paused progress for several months. 

Topic PTSD
Compound MDMA
Visit article
Category Scientific / Research
Published in New Atlas

Companies Featured

MAPS stands for Multidisciplinary Association for Psychedelic Studies, it's the front runner in making psychedelics a legal way to use (and improve) in therapy.